Art
J-GLOBAL ID:201802225677235466   Reference number:18A1986325

大うつ病性障害患者に対するセカンドライン治療における新規抗うつ薬の継続性の評価:多施設共同非盲検無作為化可変用量長期投与試験(ACCEPT研究)による検討

Author (16):
Material:
Volume: 28th  Page: 204  Publication year: 2018 
JST Material Number: L7642B  Document type: Proceedings
Article type: 会議録記事  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1986325&from=J-GLOBAL&jstjournalNo=L7642B") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for mental disorders 
Substance index (2):
Substance index
Chemical Substance indexed to the Article.

Return to Previous Page